A New Wrinkle Reducer Set To Debut This Spring

Come this spring, you may have yet another option to choose from in terms of injectables that erase, and prevent, wrinkles. Xeomin, a new botulinum toxin from the makers of Radiesse and Asclera, just received approval by the FDA to temporarily improve the appearance of lines between the eyebrows (glabellar lines).

While it's still unknown how Xeomin will be used differently than Botox or Dysport, we hear that Xeomin is formulated with less or no surrounding proteins so it's suggested that it will be less likely for the body to develop antibodies. Xeomin is also the only FDA-approved botulinum toxin that does not require refrigeration. The longer shelf life is said to be a big plus to doctors who do a lot of injections and have limited refrigerated space.

Despite the fact that Xeomin is brand new stateside, it is approved for the same manner of use in 14 countries in the EU including Germany, the UK, France, Italy and Spain, under the name Bocouture.

You'll have to wait a few more months for Xeomin to be available at your doctor's office; do you think it's worth the wait?